Current Ratio of VYNE Therapeutics Inc. from 30 Sep 2018 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
VYNE Therapeutics Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2018 to 30 Jun 2025.
  • VYNE Therapeutics Inc. Current Ratio for the quarter ending 30 Jun 2025 was 520%, a 41% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

VYNE Therapeutics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2025 520% -360% -41% 30 Jun 2025
Q1 2025 537% -294% -35% 31 Mar 2025
Q4 2024 676% +68% +11% 31 Dec 2024
Q3 2024 883% +507% +135% 30 Sep 2024
Q2 2024 880% 30 Jun 2024
Q1 2024 831% 31 Mar 2024
Q4 2023 608% 31 Dec 2023
Q3 2023 376% 30 Sep 2023
Q4 2021 346% +26% +8.1% 31 Dec 2021
Q3 2021 357% +62% +21% 30 Sep 2021
Q2 2021 368% +44% +14% 30 Jun 2021
Q1 2021 494% +138% +39% 31 Mar 2021
Q4 2020 321% -345% -52% 31 Dec 2020
Q3 2020 294% -841% -74% 30 Sep 2020
Q2 2020 324% -1002% -76% 30 Jun 2020
Q1 2020 356% -1204% -77% 31 Mar 2020
Q4 2019 666% -1090% -62% 31 Dec 2019
Q3 2019 1135% -484% -30% 30 Sep 2019
Q2 2019 1326% 30 Jun 2019
Q1 2019 1560% 31 Mar 2019
Q4 2018 1756% 31 Dec 2018
Q3 2018 1619% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.